Cargando…

Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma

Detalles Bibliográficos
Autores principales: Garrido Paniagua, Sara, Prieto Martínez, Pablo, Cachón, Rafael Forés, Bautista Carrascosa, Guiomar, Duarte, Rafael F., Krsnik, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176025/
https://www.ncbi.nlm.nih.gov/pubmed/35844696
http://dx.doi.org/10.1002/jha2.205
_version_ 1784722573564575744
author Garrido Paniagua, Sara
Prieto Martínez, Pablo
Cachón, Rafael Forés
Bautista Carrascosa, Guiomar
Duarte, Rafael F.
Krsnik, Isabel
author_facet Garrido Paniagua, Sara
Prieto Martínez, Pablo
Cachón, Rafael Forés
Bautista Carrascosa, Guiomar
Duarte, Rafael F.
Krsnik, Isabel
author_sort Garrido Paniagua, Sara
collection PubMed
description
format Online
Article
Text
id pubmed-9176025
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91760252022-07-14 Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma Garrido Paniagua, Sara Prieto Martínez, Pablo Cachón, Rafael Forés Bautista Carrascosa, Guiomar Duarte, Rafael F. Krsnik, Isabel EJHaem Haematology Images John Wiley and Sons Inc. 2021-05-07 /pmc/articles/PMC9176025/ /pubmed/35844696 http://dx.doi.org/10.1002/jha2.205 Text en © 2021 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Haematology Images
Garrido Paniagua, Sara
Prieto Martínez, Pablo
Cachón, Rafael Forés
Bautista Carrascosa, Guiomar
Duarte, Rafael F.
Krsnik, Isabel
Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma
title Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma
title_full Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma
title_fullStr Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma
title_full_unstemmed Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma
title_short Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma
title_sort secondary effects after belantamab treatment: a new anti‐b‐cell maturation antigen monoclonal antibody for multiple myeloma
topic Haematology Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176025/
https://www.ncbi.nlm.nih.gov/pubmed/35844696
http://dx.doi.org/10.1002/jha2.205
work_keys_str_mv AT garridopaniaguasara secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma
AT prietomartinezpablo secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma
AT cachonrafaelfores secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma
AT bautistacarrascosaguiomar secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma
AT duarterafaelf secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma
AT krsnikisabel secondaryeffectsafterbelantamabtreatmentanewantibcellmaturationantigenmonoclonalantibodyformultiplemyeloma